Epigenetic protein families: a new frontier for drug discovery - PubMed (original) (raw)
Review
. 2012 Apr 13;11(5):384-400.
doi: 10.1038/nrd3674.
Affiliations
- PMID: 22498752
- DOI: 10.1038/nrd3674
Review
Epigenetic protein families: a new frontier for drug discovery
Cheryl H Arrowsmith et al. Nat Rev Drug Discov. 2012.
Abstract
Epigenetic regulation of gene expression is a dynamic and reversible process that establishes normal cellular phenotypes but also contributes to human diseases. At the molecular level, epigenetic regulation involves hierarchical covalent modification of DNA and the proteins that package DNA, such as histones. Here, we review the key protein families that mediate epigenetic signalling through the acetylation and methylation of histones, including histone deacetylases, protein methyltransferases, lysine demethylases, bromodomain-containing proteins and proteins that bind to methylated histones. These protein families are emerging as druggable classes of enzymes and druggable classes of protein-protein interaction domains. In this article, we discuss the known links with disease, basic molecular mechanisms of action and recent progress in the pharmacological modulation of each class of proteins.
References
- Mutat Res. 2008 Dec 1;647(1-2):21-9 - PubMed
- Structure. 2011 Sep 7;19(9):1262-73 - PubMed
- Nature. 2007 Nov 29;450(7170):712-6 - PubMed
- J Biol Chem. 2010 Sep 10;285(37):28553-64 - PubMed
- Hum Mol Genet. 2010 Jul 15;19(14):2841-57 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources